Difference between revisions of "Succinylcholine"

Succinylcholine
Trade names	Anectine
	Clinical data
Drug class	Depolarizing neuromuscular blocker
Uses	Paralysis for intubation
Contraindications	History/risk of malignant hyperthermia; Conditions which proliferate extrajunctional acetylcholine receptors
Routes of administration	Intravenous, intramuscular
	Dosage
	Succinylcholine 1-1.5 mg/kg IV; Weight kglbg Height cmminft Age yrmowk SexFM Indication Indication: Neuromuscular blockade Route Route: IntravenousIntramuscular
	Pharmacodynamics
Mechanism of action	Depolarizing blockade of neuromuscular junction
Adverse effects	Bradycardia, hyperkalemia, malignant hyperthermia, myalgias
	Pharmacokinetics
Onset of action	30-60 seconds (IV); 2-3 minutes (IM)
Duration of action	5-10 minutes (IV); 10-30 minutes (IM)
Metabolism	Plasma cholinesterase
	Physical and chemical data
	Article quality
Editor rating	Unrated
User likes	0

Latest revision as of 16:41, 17 July 2022

Succinylcholine, also known as suxamethonium, is a short-acting neuromuscular blocker used during intubation.

@@ Line 31: / Line 31: @@
 ===Absolute contraindications<!-- List absolute contraindications for use of the drug. If none, this section may be removed. -->===
+* hyperkalemia
+* increased risk of [[Malignant Hyperthermia|malignant hyperthermia]]
+* open globe injury
+* allergy
 ===Precautions<!-- List precautions for use of the drug. If none, this section may be removed. -->===